Top Markets
Coin of the day
Regenicin, Inc. Regenicin, Inc.

Regenicin, Inc.

RGIN
Rank in Stocks #41589
Regenicin, Inc. is dedicated to the development and commercialization of... Regenicin, Inc. is dedicated to the development and commercialization of advanced tissue-engineered skin replacement technologies. Its product line features NovaDerm, a sophisticated multi-layered living and cultured skin substitute engineered for treating burn injuries, alongside TempaDerm, which addresses more localized wound areas like ulcers. These innovative solutions aim to rejuvenate the characteristics of healthy human skin, finding application in burn therapy, chronic wound management, and various plastic surgery procedures. Incorporated in 2007 and based in Little Falls, New Jersey, the company was previously known as Windstar, Inc., adopting the Regenicin, Inc. name in July 2010.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$15.35K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Regenicin, Inc. (RGIN)

Category

P/S ratio for Regenicin, Inc. (RGIN)
P/S ratio as of 2026 TTM: 0
According to Regenicin, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Regenicin, Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
9.88 -
US
10.30 -
NL
- -
CH
4.98 -
BE
- -
KR